What does Dr. Verheyen do?

Dr. Verheyen is a general practice in Ravels. Private Limited, started on 7 September 2018, 1 establishment.

What is the address of Dr. Verheyen?

The registered office of Dr. Verheyen is located at O.L.Vrouwstraat 58, 2380 Ravels.

Is Dr. Verheyen still active?

Yes. According to the CBE (17 September 2026) Dr. Verheyen is active, legal situation “Normale toestand”, started on 7 September 2018.

Is Dr. Verheyen registered on Peppol?

Yes, Dr. Verheyen is registered on the Peppol network with ID 0208:0702913666.

What is the enterprise number of Dr. Verheyen?

The enterprise number of Dr. Verheyen is BE0702913666.

When was Dr. Verheyen founded?

Dr. Verheyen was founded on 7 September 2018.

Who are the directors of Dr. Verheyen?

According to the 2025 annual accounts, the directors of Dr. Verheyen are: Margot Verheyen.

Is Dr. Verheyen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 September 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Verheyen make in 2025?

Dr. Verheyen posted a profit after taxes of € 108,510 in financial year 2025.

What is the revenue of Dr. Verheyen?

As a small company, Dr. Verheyen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 142,918.

Dr. Verheyen (Private Limited) - Ravels - BE0702913666

Dossier Dr. Verheyen, printed on 17 September 2026 from databakkes.be/en/0702913666/dr-verheyen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Verheyen from Ravels, company number BE0702913666, closed financial year 2025 with a result of € 108,510 after tax. For that financial year Dr. Verheyen recorded a gross margin of € 142,918 and equity of € 18,600. Compared with financial year 2024, the result moved from € 97,330 to € 108,510. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 108,510

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 30,976

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 108,510 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,567

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 909

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 23,132

▲ 58% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 124,636 Gross margin 2022: € 124,636 First fiscal year in the series	€ 145,261 Gross margin 2023: € 145,261 ▲ 17% vs 2022 (€ 124,636) Favourable step	€ 130,312 Gross margin 2024: € 130,312 ▼ 10% vs 2023 (€ 145,261) Unfavourable step	€ 142,918 Gross margin 2025: € 142,918 ▲ 10% vs 2024 (€ 130,312) Favourable step	▲ 10%
Profit after taxes	€ 96,794 Profit after taxes 2022: € 96,794 First fiscal year in the series	€ 110,730 Profit after taxes 2023: € 110,730 ▲ 14% vs 2022 (€ 96,794) Favourable step	€ 97,330 Profit after taxes 2024: € 97,330 ▼ 12% vs 2023 (€ 110,730) Unfavourable step	€ 108,510 Profit after taxes 2025: € 108,510 ▲ 11% vs 2024 (€ 97,330) Favourable step	▲ 11%
Equity	€ 114,585 Equity 2022: € 114,585 First fiscal year in the series	€ 18,600 Equity 2023: € 18,600 ▼ 84% vs 2022 (€ 114,585) Unfavourable step	€ 18,600 Equity 2024: € 18,600 Unchanged (€ 18,600) Unchanged	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,600) Unchanged
Total debts	€ 102,291 Total debts 2022: € 102,291 First fiscal year in the series	€ 120,439 Total debts 2023: € 120,439 ▲ 18% vs 2022 (€ 102,291) Unfavourable step	€ 98,215 Total debts 2024: € 98,215 ▼ 18% vs 2023 (€ 120,439) Favourable step	€ 116,275 Total debts 2025: € 116,275 ▲ 18% vs 2024 (€ 98,215) Unfavourable step	▲ 18%
Cash	€ 49,277 Cash 2022: € 49,277 First fiscal year in the series	€ 65,553 Cash 2023: € 65,553 ▲ 33% vs 2022 (€ 49,277) Favourable step	€ 38,274 Cash 2024: € 38,274 ▼ 42% vs 2023 (€ 65,553) Unfavourable step	€ 30,976 Cash 2025: € 30,976 ▼ 19% vs 2024 (€ 38,274) Unfavourable step	▼ 19%
Retained profit	€ 95,985 Retained profit 2022: € 95,985 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 95,985) Unfavourable step	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 96,794 Dividend 2022: € 96,794 First fiscal year in the series	€ 206,715 Dividend 2023: € 206,715 ▲ 114% vs 2022 (€ 96,794) Unchanged	€ 97,330 Dividend 2024: € 97,330 ▼ 53% vs 2023 (€ 206,715) Unchanged	€ 108,510 Dividend 2025: € 108,510 ▲ 11% vs 2024 (€ 97,330) Unchanged	▲ 11%
Balance sheet total	€ 216,876 Balance sheet total 2022: € 216,876 First fiscal year in the series	€ 139,039 Balance sheet total 2023: € 139,039 ▼ 36% vs 2022 (€ 216,876) Unchanged	€ 116,815 Balance sheet total 2024: € 116,815 ▼ 16% vs 2023 (€ 139,039) Unchanged	€ 134,875 Balance sheet total 2025: € 134,875 ▲ 15% vs 2024 (€ 116,815) Unchanged	▲ 15%

Key figures of Dr. Verheyen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Verheyen?

What happened at Dr. Verheyen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 108,510 (▲ 11% vs 2024). Source: NBB ↗
Sep 7, 2018 New establishment in Ravels. KBO
Sep 7, 2018 Start of the company according to the CBE. KBO

In short

From € 96,794 profit in 2022 to € 108,510 profit in 2025.

Paid € 120,888 in corporate taxes since 2022.

Best year ever: 2023, with € 110,730 profit.

Paid out € 509,349 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Verheyen? We notify you, reason included.

Follow Dr. Verheyen

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit